Almirall, S.A. (ALM.MC)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Carlos Gallardo Piqué | CEO, President, Member of Management Board & Chairman of the Board | 50k | -- | 1972 |
| Mr. Michael McClellan | CFO & Member of Management Board | -- | -- | 1972 |
| Mr. Eloi Crespo Cervera | Chief Industrial Operations Officer & Member of Management Board | -- | -- | -- |
| Mr. Esteve Conesa Panicot | Chief People & Culture Officer and Member of Management Board | -- | -- | -- |
| Dr. Volker Koscielny | Chief Medical Officer & Member of Management Board | -- | -- | -- |
| Dr. Karl Ziegelbauer | Chief Scientific Officer & Member of Management Board | -- | -- | -- |
| Mr. Paolo Cionini | Chief Commercial Officer Europe & International and Member of Management Board | -- | -- | -- |
| Ms. Isabel Cristina Gomes | Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board | -- | -- | -- |
| Ms. Mercedes Diz Lopez | Chief Marketing Officer & Member of Management Board | -- | -- | -- |
| Mr. Paul Rittman | Member of Management Board and President & GM of Almirall US | -- | -- | -- |
Almirall, S.A.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 2,026
Description
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immunostimulants; metabolism; and systematic hormonal preparations. It has a multi-target partnership with Etherna to research and develop mRNA-based therapies for medical dermatology. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Corporate Governance
Upcoming Events
May 12, 2025 at 5:28 AM UTC - May 16, 2025 at 5:28 AM UTC
Almirall, S.A. Earnings Date
Recent Events
May 17, 2024 at 12:00 AM UTC
Ex-Dividend Date